COc1ccc(C[C@H](N)C(=O)N2C[C@@H](CO)C[C@@H](n3ccc(=O)[nH]c3=O)C2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?